bf/NYSE:BSX_icon.jpeg

NYSE:BSX

Boston Scientific Corporation

  • Stock

USD

Last Close

74.26

26/07 20:00

Market Cap

113.37B

Beta: 0.80

Volume Today

6.55M

Avg: 8.81M

PE Ratio

77.02

PFCF: 58.40

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
890.50M
-
921.50M
3.48%
981M
6.46%
985.50M
0.46%
1.02B
3.15%
1.12B
10.38%
1.37B
22.33%
1.47B
6.74%
1.48B
1.06%
1.74B
17.43%
2.18B
25.14%
average payables
239M
-
254M
6.28%
235.50M
7.28%
328M
39.28%
488.50M
48.93%
439.50M
10.03%
445.50M
1.37%
527.50M
18.41%
653.50M
23.89%
828M
26.70%
902M
8.94%
average receivables
1.26B
-
1.25B
1.35%
1.23B
1.29%
1.37B
11.76%
1.51B
9.94%
1.58B
4.50%
1.77B
12.20%
1.73B
2.17%
1.65B
4.47%
1.87B
13.27%
2.10B
12.01%
book value per share
4.88
-
5.17
5.98%
4.71
8.81%
4.96
5.25%
5.12
3.18%
6.32
23.47%
9.97
57.85%
10.82
8.48%
11.69
8.03%
12.29
5.11%
13.17
7.24%
capex per share
-0.18
-
-0.20
7.06%
-0.18
5.83%
-0.28
50.39%
-0.23
15.93%
-0.23
1.72%
-0.33
44.79%
-0.27
19.89%
-0.39
46.76%
-0.43
9.84%
-0.55
27.77%
capex to depreciation
-0.36
-
-0.36
0.47%
-0.32
10.09%
-0.46
43.63%
-0.38
18.07%
-0.35
6.48%
-0.46
29.00%
-0.33
26.57%
-0.51
51.38%
-0.54
6.29%
-0.67
24.16%
capex to operating cash flow
-0.23
-
-0.20
9.86%
-0.41
101.70%
-0.39
6.03%
-0.22
42.17%
-1.02
355.67%
-0.25
75.37%
-0.25
0.70%
-0.30
18.82%
-0.40
35.37%
-0.32
20.30%
capex to revenue
-0.03
-
-0.04
2.32%
-0.03
5.87%
-0.04
35.73%
-0.04
21.37%
-0.03
8.76%
-0.04
33.49%
-0.04
11.67%
-0.05
22.86%
-0.05
3.55%
-0.06
16.42%
cash per share
0.16
-
0.44
173.96%
0.24
46.34%
0.14
39.30%
0.14
4.96%
0.11
22.95%
0.16
47.51%
1.22
684.86%
1.35
10.58%
0.65
52.07%
0.59
8.89%
days of inventory on hand
141.49
-
148.77
5.14%
165.33
11.13%
139.26
15.77%
147.87
6.18%
147.62
0.17%
181.18
22.73%
140.49
22.46%
156.29
11.25%
170.24
8.92%
208.67
22.58%
days payables outstanding
38.80
-
41.20
6.18%
34.01
17.45%
65.18
91.66%
72.70
11.53%
44.18
39.22%
62.19
40.75%
53.35
14.22%
77.08
44.48%
78.60
1.97%
79.13
0.68%
days sales outstanding
66.79
-
58.51
12.39%
62.24
6.38%
64.07
2.94%
62.45
2.53%
59.75
4.32%
65.72
10.00%
56.37
14.23%
54.59
3.16%
56.70
3.86%
57.11
0.72%
debt to assets
0.25
-
0.25
0.05%
0.31
23.63%
0.30
3.20%
0.29
3.33%
0.33
14.28%
0.34
0.43%
0.31
7.82%
0.29
5.39%
0.29
2.51%
0.27
5.50%
debt to equity
0.65
-
0.62
3.95%
0.90
44.22%
0.81
9.33%
0.80
2.32%
0.81
1.27%
0.74
8.09%
0.62
15.96%
0.57
8.65%
0.53
7.10%
0.49
6.79%
dividend yield
0.11
-
0.04
60.82%
0.00
-
0.00
65.58%
0.00
8.72%
0.00
60.17%
earnings yield
-0.01
-
0.02
302.73%
-0.01
163.51%
0.01
222.28%
0.00
74.09%
0.03
1,018.18%
0.07
118.16%
-0.00
103.68%
0.02
726.79%
0.01
38.79%
0.02
78.55%
enterprise value
20.14B
-
21.22B
5.35%
30.09B
41.79%
34.65B
15.17%
39.35B
13.57%
55.69B
41.50%
72.98B
31.06%
58.74B
19.52%
67.95B
15.68%
74.54B
9.71%
93.23B
25.07%
enterprise value over ebitda
15.80
-
15.74
0.35%
20.81
32.18%
18.97
8.85%
19.95
5.16%
23.06
15.61%
35.05
52.02%
32.04
8.59%
24.41
23.84%
26.62
9.08%
25.75
3.26%
ev to operating cash flow
18.62
-
16.72
10.17%
50.15
199.88%
35.65
28.91%
27.60
22.59%
179.64
550.92%
39.75
77.87%
38.95
2.02%
36.33
6.71%
48.85
34.44%
37.25
23.75%
ev to sales
2.82
-
2.88
1.97%
4.02
39.95%
4.13
2.68%
4.35
5.26%
5.67
30.34%
6.80
19.92%
5.93
12.85%
5.72
3.54%
5.88
2.84%
6.55
11.39%
free cash flow per share
0.62
-
0.76
22.21%
0.26
65.49%
0.44
66.80%
0.81
84.04%
-0.00
100.54%
0.99
22,843.74%
0.80
19.14%
0.93
15.80%
0.64
30.95%
1.16
82.12%
free cash flow yield
0.05
-
0.06
10.86%
0.01
75.20%
0.02
42.20%
0.03
60.58%
-0.00
100.38%
0.02
17,874.52%
0.02
1.71%
0.02
2.00%
0.01
36.60%
0.02
45.77%
graham net net
-6.37
-
-6.07
4.76%
-7.48
23.18%
-7.06
5.58%
-7.40
4.84%
-7.49
1.13%
-10.23
36.63%
-8.40
17.92%
-8.12
3.32%
-8.08
0.46%
-8.08
0.04%
graham number
3.15
-
4.84
53.90%
4.35
10.22%
5.34
22.87%
2.96
44.64%
13.12
343.63%
27.53
109.91%
4.90
82.18%
13.87
182.86%
11.61
16.29%
17.96
54.67%
income quality
-8.94
-
-10.66
19.25%
-2.51
76.46%
2.80
211.58%
13.71
389.50%
0.19
98.65%
0.39
110.57%
-18.39
4,807.74%
1.80
109.77%
2.19
21.70%
1.57
28.09%
intangibles to total assets
0.70
-
0.68
1.76%
0.70
2.20%
0.69
0.63%
0.67
2.89%
0.68
0.91%
0.59
13.12%
0.52
12.76%
0.56
8.98%
0.58
3.18%
0.58
0.11%
interest coverage
0.37
-
1.38
273.75%
-1.15
183.18%
1.92
266.62%
5.61
192.49%
6.25
11.36%
3.21
48.64%
2.89
9.89%
5.99
107.17%
3.51
41.44%
8.84
152.00%
interest debt per share
3.40
-
3.38
0.63%
4.44
31.44%
4.21
5.25%
4.24
0.65%
5.27
24.22%
7.73
46.73%
6.99
9.55%
6.88
1.48%
6.82
0.98%
6.67
2.20%
inventory turnover
2.58
-
2.45
4.89%
2.21
10.02%
2.62
18.72%
2.47
5.82%
2.47
0.17%
2.01
18.52%
2.60
28.96%
2.34
10.11%
2.14
8.19%
1.75
18.42%
invested capital
0.65
-
0.62
3.95%
0.90
44.22%
0.81
9.33%
0.80
2.32%
0.81
1.27%
0.74
8.09%
0.62
15.96%
0.57
8.65%
0.53
7.10%
0.49
6.79%
market cap
16.12B
-
17.55B
8.84%
24.73B
40.95%
29.36B
18.73%
33.96B
15.66%
48.80B
43.69%
62.92B
28.93%
50.93B
19.06%
60.42B
18.63%
66.19B
9.55%
84.60B
27.82%
net current asset value
-7.02B
-
-6.59B
6.11%
-8.34B
26.53%
-8.12B
2.61%
-8.21B
1.03%
-8.27B
0.76%
-11.99B
44.97%
-8.76B
26.96%
-9.29B
6.09%
-9.14B
1.66%
-9.09B
0.48%
net debt to ebitda
3.16
-
2.73
13.60%
3.71
35.91%
2.89
21.89%
2.73
5.61%
2.85
4.34%
4.83
69.51%
4.26
11.88%
2.70
36.51%
2.98
10.37%
2.38
20.12%
net income per share
-0.09
-
0.20
323.48%
-0.18
188.39%
0.26
243.43%
0.08
70.30%
1.21
1,494.05%
3.38
179.15%
-0.10
102.93%
0.73
840.64%
0.49
33.33%
1.09
123.08%
operating cash flow per share
0.81
-
0.96
18.78%
0.45
53.31%
0.72
60.04%
1.04
45.37%
0.22
78.43%
1.32
487.79%
1.06
19.33%
1.31
23.52%
1.07
18.86%
1.71
60.33%
payables turnover
9.41
-
8.86
5.82%
10.73
21.15%
5.60
47.82%
5.02
10.34%
8.26
64.53%
5.87
28.95%
6.84
16.58%
4.74
30.79%
4.64
1.94%
4.61
0.67%
receivables turnover
5.47
-
6.24
14.15%
5.86
6.00%
5.70
2.85%
5.84
2.60%
6.11
4.51%
5.55
9.09%
6.47
16.59%
6.69
3.26%
6.44
3.72%
6.39
0.72%
research and ddevelopement to revenue
0.12
-
0.11
8.16%
0.12
5.83%
0.11
6.36%
0.11
0.44%
0.11
2.83%
0.11
3.48%
0.12
5.43%
0.10
12.16%
0.10
3.00%
0.10
4.82%
return on tangible assets
-0.02
-
0.05
310.92%
-0.04
187.22%
0.06
243.38%
0.02
73.27%
0.25
1,384.94%
0.38
51.06%
-0.01
102.50%
0.07
885.11%
0.05
30.62%
0.11
111.21%
revenue per share
5.33
-
5.57
4.64%
5.57
0.04%
6.18
10.80%
6.60
6.91%
7.11
7.71%
7.71
8.46%
7.00
9.30%
8.36
19.45%
8.87
6.07%
9.73
9.75%
roe
-0.02
-
0.04
310.86%
-0.04
196.92%
0.05
236.28%
0.01
71.22%
0.19
1,191.09%
0.34
76.84%
-0.01
102.70%
0.06
785.60%
0.04
36.58%
0.08
108.02%
roic
0.01
-
0.08
1,207.79%
-0.01
112.69%
0.07
815.71%
0.01
83.99%
0.11
877.54%
0.42
278.50%
0.04
90.14%
0.07
78.02%
0.04
50.30%
0.06
73.76%
sales general and administrative to revenue
0.37
-
0.39
5.04%
0.38
2.28%
0.37
3.83%
0.36
1.48%
0.36
0.20%
shareholders equity per share
4.88
-
5.17
5.98%
4.71
8.81%
4.96
5.25%
5.12
3.18%
6.32
23.47%
9.97
57.85%
10.82
8.48%
11.69
8.03%
12.29
5.11%
13.17
7.24%
stock based compensation to revenue
0.01
-
0.01
5.05%
0.01
2.54%
0.01
3.34%
0.01
1.47%
0.01
1.54%
0.01
2.62%
0.02
17.26%
0.02
4.84%
0.02
6.30%
0.02
5.68%
tangible asset value
-5.10B
-
-4.66B
8.68%
-6.35B
36.17%
-5.83B
8.18%
-5.82B
0.07%
-5.56B
4.57%
-4.18B
24.70%
-540M
87.10%
-1.49B
175%
-1.25B
15.89%
-860M
31.14%
tangible book value per share
-3.81
-
-3.52
7.51%
-4.73
34.46%
-4.29
9.29%
-4.25
0.98%
-4.02
5.32%
-3.01
25.27%
-0.38
87.33%
-1.04
173.92%
-0.87
16.37%
-0.59
32.70%
working capital
1.35B
-
1.15B
14.90%
1.04B
9.32%
-348M
133.43%
-1.83B
426.44%
-1.26B
31.39%
-167M
86.71%
3.01B
1,904.19%
2.04B
32.19%
1.96B
4.21%
1.58B
19.21%

All numbers in USD (except ratios and percentages)